Early results from tests for a coronavirus vaccine being developed by the University of Oxford, in collaboration with AstraZeneca, show it produces a robust immune response in elderly people, the group at highest risk, the Financial Times reports.
Researchers discovered the vaccine triggered protective antibodies and T-cells in older age groups, the newspaper reported on Monday, citing two people familiar with the finding, encouraging scientists as they seek evidence that it will spare those in…
Early results in as COVID vaccine frontrunner by Oxford University and AstraZeneca tested on high risk groups – 7NEWS.com.au
- Advertisment -
